Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
DRD4P21917D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor)7Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation20.50
EAA4P48664Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins8Fusion and delivery mediation20.50
ECSCRQ19T08Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression) (ARIA) (Endothelial cell-specific molecule 2)1Other mediation20.50
EDNRBP24530Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type)Disease related genesFDA approved drug targetsG-protein coupled receptors7Cardiac arrhythmiaCardiovascular diseaseEncephalopathyClinical-translation mediationFusion and delivery mediationImmune mediation20.50
EPHB2P29323Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2]Cancer-related genesDisease related genesEnzymes1Kaposi sarcomaMelanomaPancreatic cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
F1711Q5VUB5Protein FAM171A1 (Astroprincin) (APCN)Predicted intracellular proteinsPredicted membrane proteins1Fusion and delivery mediation20.50
FFAR1O14842Free fatty acid receptor 1 (G-protein coupled receptor 40)7Fusion and delivery mediationImmune mediationMetabolism mediation20.50
FZD4Q9ULV1Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344)CD markersDisease related genesG-protein coupled receptors7Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
GABR1Q9UBS5Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)FDA approved drug targetsG-protein coupled receptorsPlasma proteins7Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
GFRALQ6UXV0GDNF family receptor alpha-likePredicted membrane proteins1Solid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
GLRA1P23415Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)4SepsisTonus and reflex abnormalityClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
GLT10Q86SR1Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)EnzymesMetabolic proteinsPredicted intracellular proteins1Metabolism mediation20.50
GLT12Q8IXK2Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12)Disease related genesEnzymesHuman disease related genes1Clinical-translation mediationMetabolism mediation20.50
GRIK5Q16478Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)3Fusion and delivery mediationReceptor-signaling mediation20.50
GTR1P11166Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)Cancer-related genesDisease related genesHuman disease related genes12Skin diseaseClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
GTR12Q8TD20Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)Metabolic proteinsPredicted membrane proteinsTransporters12Fusion and delivery mediation20.50
GTR14Q8TDB8Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14)Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins12Fusion and delivery mediation20.50
HLAAP04439HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)1Acute myeloid leukaemiaAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
IFM1P13164Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Interferon-induced protein 17) (Interferon-inducible protein 9-27) (Leu-13 antigen) (CD antigen CD225)CD markersPlasma proteinsPredicted membrane proteins1Fusion and delivery mediationImmune mediation20.50
ILRL1Q01638Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2)Candidate cardiovascular disease genesEnzymesPlasma proteins1AsthmaChronic obstructive pulmonary diseaseAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
ITA8P53708Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]Disease related genesHuman disease related genesPlasma proteins1Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation20.50
ITAXP20702Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)CD markersFDA approved drug targetsPredicted intracellular proteins1Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
KCNH8Q96L42Voltage-gated delayed rectifier potassium channel KCNH8 (ELK1) (hElk-1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Potassium voltage-gated channel subfamily H member 8) (Voltage-gated potassium channel subunit Kv12.1)Predicted membrane proteinsVoltage-gated ion channels6Clinical-translation mediationFusion and delivery mediation20.50
KCNKHQ96T54Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2) (TALK-2)Predicted membrane proteinsTransportersVoltage-gated ion channels4Fusion and delivery mediation20.50
KCNU1A8MYU2Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)7Fusion and delivery mediation20.50

251-275 of 1,200 proteins

Page